<Record>
<Term>Human MOAB LICO 28a32</Term>
<SemanticType>Pharmacologic Substance</SemanticType>
<ParentTerm>Monoclonal Antibody</ParentTerm>
<ClassificationPath>Chemicals_and_Drugs_Kind/Drug, Food, Chemical or Biomedical Material/Pharmacologic Substance/Biological Agent/Monoclonal Antibody/Human MOAB LICO 28a32</ClassificationPath>
<BroaderTerm>Chemicals_and_Drugs_Kind</BroaderTerm>
<BroaderTerm>Biological Agent</BroaderTerm>
<BroaderTerm>Pharmacologic Substance</BroaderTerm>
<BroaderTerm>Monoclonal Antibody</BroaderTerm>
<BroaderTerm>Human MOAB LICO 28a32</BroaderTerm>
<BroaderTerm>Drug, Food, Chemical or Biomedical Material</BroaderTerm>
<Synonym>Human MOAB LICO 28a32</Synonym>
<Description>A human monoclonal immunoglobulin M (IgM) antibody with potential antineoplastic activity.  Human MOAB LICO 28a32 binds to the colon tumor-associated antigen 28A32 (CTAA 28A32) found on the cell surface and in the cytoplasm of colon carcinoma cells. (NCI04)</Description>
<Source>NCI Thesaurus</Source>
</Record>
